Dr. Daniel Alencar Rodrigues


Daniel Alencar Rodrigues obtained a B.Sc. degree in Pharmacy in 2013 from the Federal University of Goiás (Goiás – Brazil). He obtained a M.Sc. degree in Sciences (Chemistry) in 2015 and Ph.D. in Chemistry in 2019 from the Federal University of Rio de Janeiro (UFRJ – Brazil).  His M.Sc. and Ph.D. were focused on the design, synthesis, molecular modeling studies and pharmacological evaluation of novel HDAC inhibitors and multi-target ligands based on HDAC inhibitors.

Daniel joined Dr. Ní Chonghaile’s research group in 2020 and he is now employed as a post-doctoral researcher with funding from the Science Foundation Ireland at the Royal College of Surgeons in Dublin where he is involved in the project HDAC6i: Understanding the function and targeting HDAC6 in triple-negative breast cancer.